Health & Well-Being
Study: USDA’s Child and Adult Care Food Program Underused By Connecticut Child Care Centers
Low program awareness and burdensome paperwork cited as common reasons for lack of participation, which costs the state millions in foregone federal fund
December 6, 2021 | Kristin Messina, UConn Rudd Center
Connecticut Urges Other States to Adapt Rapid Opioid Overdose Surveillance
As deadly overdoses spike, the ability to respond quickly becomes ever more urgent
December 2, 2021 | Lauren Woods
Elite Expertise in Brain and Spine Disorders
Two physicians from the Brain and Spine Institute describe UConn Health's collaborative approach to treating those suffering from brain tumors, strokes, and other disorders of the brain and spine.
November 30, 2021 | Chris DeFrancesco '94 (CLAS)
Companies are Pushing Sweetened Drinks to Children through Ads and Misleading Labels – and Families are Buying
There are dozens of options for children’s drinks in most supermarkets. Choosing the healthy options is difficult
November 23, 2021 | Fran Fleming-Milici, Director of Marketing Initiatives, UConn Rudd Center for Food Policy and Health
UConn Researchers: Deleting Dysfunctional Cells Alleviates Diabetes
A discovery that could lead to game-changing treatments for metabolic diseases
November 22, 2021 | Kim Krieger
The FDA’s Lax Oversight of Research in Developing Countries Can Do Harm to Vulnerable Participants
No on-site inspections, fraudulent data, and patients who didn't know they were participating in a clinical trial
November 19, 2021 | C. Michael White, Distinguished Professor and Head of the Department of Pharmacy Practice
Behind the Degree: DNP Student Plans to Use Her Advanced Education to Empower Her Patients and Other Nurses
Savitha Chandramohan is earning her Doctor of Nursing Practice degree so she can support development among her fellow nurses and reduce patients' costly hospital visits
November 18, 2021 | Rachel Antonelli
TIP Company ImStem Biotechnology Doses First MS Patient in Clinical Trial
UConn TIP company ImSTEM Biotechnology is conducting a clinical trial to test their experimental human embryonic stem cell-derived mesenchymal stem cell therapy for the treatment of multiple sclerosis.
November 18, 2021 | Anna Zarra Aldrich '20 (CLAS), Office of the Vice President for Research
10 Ways to Beat the Holiday Blues (Starting Now)
Feeling stressed already? You're not alone
November 17, 2021 | Lauren Woods
Q&A: The Challenges of Pandemic-Era Readjustment for Children and Adolescents
Dr. Asima Zehgeer of UConn Health’s Child and Adolescent Psychiatry Outpatient Clinic discusses challenges faced by children and teens in the wake of COVID-19
November 10, 2021 | Chris DeFrancesco '94 (CLAS)